142 related articles for article (PubMed ID: 18258607)
21. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
Koehl GE; Spitzner M; Ousingsawat J; Schreiber R; Geissler EK; Kunzelmann K
Oncogene; 2010 Mar; 29(10):1553-60. PubMed ID: 19966863
[TBL] [Abstract][Full Text] [Related]
22. Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice.
Otani K; Kitayama J; Yasuda K; Nio Y; Iwabu M; Okudaira S; Aoki J; Yamauchi T; Kadowaki T; Nagawa H
Cancer Lett; 2010 Feb; 288(2):177-82. PubMed ID: 19646806
[TBL] [Abstract][Full Text] [Related]
23. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.
Witkowski P; Seki T; Xiang G; Martens T; Sondermeijer H; See F; Bhagat G; Schuster M; Hardy MA; Itescu S
J Cardiovasc Pharmacol; 2007 Dec; 50(6):633-40. PubMed ID: 18091579
[TBL] [Abstract][Full Text] [Related]
24. Dietary carbohydrate source alters gene expression profile of intestinal epithelium in mice.
Wang B; Bobe G; LaPres JJ; Bourquin LD
Nutr Cancer; 2009; 61(1):146-55. PubMed ID: 19116885
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
26. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium.
Ding S; McEntee MF; Whelan J; Zemel M
Nutr Cancer; 2007; 58(2):153-61. PubMed ID: 17640161
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
28. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
Oishi K; Miyazaki K; Uchida D; Ohkura N; Wakabayashi M; Doi R; Matsuda J; Ishida N
J Mol Cell Cardiol; 2009 Apr; 46(4):545-52. PubMed ID: 19168071
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development.
Lijnen HR; Frederix L; Scroyen I
J Thromb Haemost; 2007 Nov; 5(11):2259-65. PubMed ID: 17958744
[TBL] [Abstract][Full Text] [Related]
30. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
[TBL] [Abstract][Full Text] [Related]
31. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver.
Steffensen IL; Schut HA; Alexander J
Mutat Res; 2005 Nov; 587(1-2):73-89. PubMed ID: 16202642
[TBL] [Abstract][Full Text] [Related]
32. Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice.
Mehl KA; Davis JM; Clements JM; Berger FG; Pena MM; Carson JA
J Appl Physiol (1985); 2005 Jun; 98(6):2219-25. PubMed ID: 15894538
[TBL] [Abstract][Full Text] [Related]
33. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
Abderrahmani R; François A; Buard V; Benderitter M; Sabourin JC; Crandall DL; Milliat F
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):942-8. PubMed ID: 19480973
[TBL] [Abstract][Full Text] [Related]
34. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
36. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
Koratkar R; Pequignot E; Hauck WW; Siracusa LD
Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
[TBL] [Abstract][Full Text] [Related]
37. Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apc min/+ mice.
Lawrance AK; Deng L; Rozen R
Gut; 2009 Jun; 58(6):805-11. PubMed ID: 19174418
[TBL] [Abstract][Full Text] [Related]
38. High sucrose diets promote intestinal epithelial cell proliferation and tumorigenesis in APC(Min) mice by increasing insulin and IGF-I levels.
Wang B; Bobe G; LaPres JJ; Bourquin LD
Nutr Cancer; 2009; 61(1):81-93. PubMed ID: 19116878
[TBL] [Abstract][Full Text] [Related]
39. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
[TBL] [Abstract][Full Text] [Related]
40. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy.
Backshall A; Alferez D; Teichert F; Wilson ID; Wilkinson RW; Goodlad RA; Keun HC
J Proteome Res; 2009 Mar; 8(3):1423-30. PubMed ID: 19159281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
